Envestnet Asset Management Inc. Trims Holdings in HealthSouth Corp (HLS)

Envestnet Asset Management Inc. lessened its position in HealthSouth Corp (NYSE:HLS) by 54.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 12,314 shares of the company’s stock after selling 14,600 shares during the period. Envestnet Asset Management Inc.’s holdings in HealthSouth were worth $569,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in HLS. TimesSquare Capital Management LLC purchased a new position in shares of HealthSouth during the second quarter valued at approximately $37,868,000. APG Asset Management N.V. purchased a new position in shares of HealthSouth during the third quarter valued at approximately $27,082,000. Balyasny Asset Management LLC boosted its position in shares of HealthSouth by 421.4% during the second quarter. Balyasny Asset Management LLC now owns 618,311 shares of the company’s stock valued at $29,926,000 after buying an additional 499,715 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of HealthSouth by 4.6% during the second quarter. Vanguard Group Inc. now owns 7,532,456 shares of the company’s stock valued at $364,571,000 after buying an additional 328,081 shares during the last quarter. Finally, Prudential Financial Inc. boosted its position in shares of HealthSouth by 137.1% during the second quarter. Prudential Financial Inc. now owns 434,679 shares of the company’s stock valued at $21,039,000 after buying an additional 251,372 shares during the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.

Several research analysts recently issued reports on the company. SunTrust Banks set a $58.00 target price on HealthSouth and gave the company a “buy” rating in a research report on Thursday. Robert W. Baird reaffirmed a “buy” rating and set a $55.00 target price on shares of HealthSouth in a research report on Monday, October 9th. Zacks Investment Research upgraded HealthSouth from a “hold” rating to a “buy” rating and set a $52.00 price target on the stock in a report on Monday, October 30th. KeyCorp reiterated a “hold” rating on shares of HealthSouth in a report on Thursday, September 7th. Finally, Royal Bank of Canada reiterated a “buy” rating and set a $55.00 price target on shares of HealthSouth in a report on Wednesday, September 6th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $52.44.

Shares of HealthSouth Corp (HLS) opened at $49.32 on Friday. The company has a market capitalization of $4,840.82, a price-to-earnings ratio of 17.93, a P/E/G ratio of 1.81 and a beta of 0.54. HealthSouth Corp has a fifty-two week low of $38.24 and a fifty-two week high of $50.41. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 1.89.

HealthSouth (NYSE:HLS) last issued its quarterly earnings results on Thursday, October 26th. The company reported $0.66 EPS for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. The business had revenue of $995.60 million for the quarter, compared to analyst estimates of $985.75 million. HealthSouth had a return on equity of 22.81% and a net margin of 6.69%. HealthSouth’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company posted $0.65 earnings per share. analysts anticipate that HealthSouth Corp will post 2.72 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Tuesday, January 2nd will be issued a dividend of $0.25 per share. The ex-dividend date is Friday, December 29th. This represents a $1.00 dividend on an annualized basis and a yield of 2.03%. HealthSouth’s dividend payout ratio (DPR) is currently 36.36%.

In other HealthSouth news, Director Yvonne M. Curl purchased 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 1st. The shares were acquired at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the completion of the acquisition, the director now owns 64,144 shares of the company’s stock, valued at approximately $2,947,416.80. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.60% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Envestnet Asset Management Inc. Trims Holdings in HealthSouth Corp (HLS)” was posted by Community Financial News and is the property of of Community Financial News. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.com-unik.info/2017/12/23/envestnet-asset-management-inc-trims-holdings-in-healthsouth-corp-hls.html.

HealthSouth Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Institutional Ownership by Quarter for HealthSouth (NYSE:HLS)

Receive News & Ratings for HealthSouth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit